Gene Query: NCOA2

Dataset Description Geneva Score
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 48.99
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 35.32
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 30.26
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 28.26
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 27.44
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 27.44
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 25.32
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 25.07
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 24.63
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 24.34
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 22.22
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 22.22
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 21.95
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 21.45
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 20.54
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 20.3
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 20.23
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 19.52
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 18.86
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 18.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 17.97
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 17.63
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 17.59
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 17.55
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 17.49
Global analyses of the effect of different cellular contexts on microRNA targeting 17.49
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 17.37
RIG-I and MDA5 fRIP during KSHV lytic reactivation 17.12
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 17.09
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 16.16
The regulartory role of ZCCHC24 in splicing machinery 14.83
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 14.73
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 14.5
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 14.5
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 14.41
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 14.37
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 14.16
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 14.16
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 14.15
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 14.15
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 14.02
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 13.98
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 13.78
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 13.75
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 13.65
Genome-wide functional assessment of enhancer activities in the human genome 13.54
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 13.47
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 13.4
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 13.4
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.23
Dtx3L and Androgen Signaling in Prostate Cancer 13.17
Selective expression of long non-coding RNAs in a breast cancer cell progression model 13.17
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 13.07
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.95
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.95
Human Treg IFNg/IL-10 subpopulations 12.89
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.88
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 12.79
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 12.79
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 12.64
IL-33 activates tumor stroma to promote intestinal polyposis 12.58
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 12.38
The cytokine environment influence on human skin-derived T cells 12.21
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 12.16
Gene expressions of H9s in different culture systems 12.15
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 12.15
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 12.12
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 12.07
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 12.07
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 12.07
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 12.0
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.89
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.83
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.83
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 11.78
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 11.63
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 11.62
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 11.6
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 11.6
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 11.6
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.59
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 11.58
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 11.48
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 11.4
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.38
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.31
Role for citron kinase in prostate cancer growth 11.28
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.26
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 11.26
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 11.26
Transcriptome-wide identification of CELF2 functional targets in T cells 11.25
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 11.09
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 11.06
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 11.06
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 11.06
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 10.97
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.93
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.78
Depicting early human development and germ cell origin with porcine embryos 10.78
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 10.61
RNAseq of cell lines with knocked in ESR1 mutations 10.6
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 10.6
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.6
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.6
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 10.6
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 10.57
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 10.57
MARCKS and lnc-MARCKS act as inflammation regulators 10.48
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 10.4
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 10.4
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 10.35
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 10.28
Mapping interactions for the TNIP2 hub protein 10.26
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 10.23
Genes significantly down or Up-regulated upon RNF219 knockdown 10.22
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 10.21
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 10.16
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 10.06
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 10.06
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 10.01
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 10.01
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 9.91
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 9.89
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 9.74
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 9.74
RNA-seq analyses of human prostate cancer cells 9.74
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 9.72
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 9.68
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 9.65
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 9.49
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 9.4
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 9.4
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 9.16
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 9.11
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 9.11
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 9.07
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.06
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 9.04
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.04
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.04
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 8.99
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.97
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.79
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.76
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.76
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.74
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 8.72
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 8.7
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.62
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 8.6
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 8.59
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 8.58
DRB/GRO-Seq -/+ UV 8.53
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 8.43
Entrectinib Resistance in a Neuroblastoma Xenograft Model 8.41
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 8.41
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 8.39
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 8.37
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 8.37
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.35
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.35
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.34
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.26
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 8.21
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 8.21
Hepatosplenic T cell lymphoma 8.17
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 8.17
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 8.17
Gene expression profiling of leukemia cells following asparagine depletion 8.08
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.05
MYC dependent mRNA translation shapes gene expression and cell biology 8.02
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.91
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 7.9
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.87
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 7.86
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.82
IMP3 regulated gene expression in breast cancer cells 7.82
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 7.82
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 7.79
Primate transcript and protein expression levels evolve under compensatory selection pressures 7.79
Real-time observation of light-controlled transcription in living cells 7.79
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.77
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.76
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 7.74
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 7.74
Genome-wide chromatin analysis of Ewing sarcoma 7.74
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.73
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 7.73
A prostate cancer chromatin interaction map 7.71
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.68
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 7.63
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 7.62
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 7.61
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 7.61
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 7.61
RNA-seq of YB5 cells treated with Proscillaridin A 7.61
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.61
The cohesin complex prevents Myc-induced replication stress 7.6
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.58
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 7.57
Transcriptomic analysis of ERR alpha orphan nuclear receptor 7.56
Primary human trophoblast from term placenta 7.53
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 7.49
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.46
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.43
LINE-2 transposable elements are a source of functional human microRNAs and target sites 7.42
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.38
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.37
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 7.36
Neonatal and adult human testis defined at the single-cell level 7.32
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 7.31
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 7.3
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 7.25
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 7.22
Examining serotonergic neuron differentiation from human iPSCs 7.2
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 7.2
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 7.18
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 7.18
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 7.18
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.17
Defective structural RNA processing in relapsing-remitting multiple sclerosis 7.16
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.16
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.16
Transcriptomic analysis of LSD1 7.15
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.15
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.14
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 7.13
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.13
CD86 regulates a pro-survival signal in myeloma cells 7.08
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 7.03
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 7.03
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 7.02
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 7.01
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.91
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.89
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.86
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.86
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 6.85
Human neutrophil genome during PMA- and E. coli encounter-induced activation 6.85
Stem and effector CD8 T-cells from human cancers 6.85
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 6.84
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 6.84
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.81
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.78
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 6.76
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 6.76
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 6.75
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 6.74
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 6.73
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 6.72
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 6.72
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 6.72
U1 snRNP telescripting regulates size-function stratified human genome 6.62
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.56
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.54
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.54
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 6.51
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 6.51
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.5
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 6.5
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 6.49
LIN28A modulates splicing and gene expression programs in breast cancer cells 6.49
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 6.48
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 6.44
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 6.44
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 6.42
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 6.41
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 6.38
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 6.38
Transcription elongation regulates genome 3D structure 6.38
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 6.3
A map of gene expression in neutrophil-like cell lines 6.21
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.19
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.16
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.14
RNA sequencing of primary human platelets and in vitro cell lines 6.08
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.07
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.07
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.07
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.05
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 6.03
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 5.98
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.98
The transcriptome effect of overexpressing EZH2 in MCF7 5.98
Targeting MTHFD2 in Acute Myeloid Leukemia 5.87
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.86
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 5.77
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 5.73
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.72
Disruption of the exocyst induces podocyte loss and dysfunction 5.7
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.68
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 5.67
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 5.67
RNA expression analysis upon JMJD1C depletion 5.55
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.55
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 5.51
Expression profiling of MCF-7 cells with treatment of TCDD 5.4
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.4
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.35
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.34
RNA-seq analysis of control and Myc-induced U2OS cells 5.34
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 5.33
RNA-seq analysis upon ARID1B overexpression 5.32
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 5.28
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.27
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.22
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.19
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.19
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.17
Hypoxic transcriptome of SQ20B human head and neck cancer cells 5.16
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.09
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.08
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 5.05
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.02
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.99
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.98
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.98
The cohesin release factor WAPL restricts chromatin loop extension. 4.97
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.97
RNA-seq differential expression studies: more sequence, or more replication? 4.95
Seletive inhibition of CDK9 in DLBCL cell lines 4.94
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 4.94
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.94
NR2F2 study 4.89
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 4.89
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 4.82
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 4.82
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.81
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.79
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 4.76
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.7
p53 activity results in DNA replication fork processivity 4.6
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.56
Effects of rFVIIIFc on human macrophages 4.52
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.48
Human Treg NaCl stimulation 4.47
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.45
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 4.43
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.37
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.35
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 4.32
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.27
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 4.17
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 4.15
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.09
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.06
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 4.02
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.0
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 3.99
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.98
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.86
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.86
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.85
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.81
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.62
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 3.6
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 3.56
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 3.56
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.55
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.53
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.51
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.48
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.48
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.45
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.4
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.4
Expression data from miR340 overexpressing human A549 cells 3.35
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.32
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.3
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 3.24
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.23
CD74 role in transcription regulation [RNA-seq] 3.19
CD74 role in transcription regulation 3.19
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.18
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.18
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.16
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.12
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.11
Genome-wide Analysis of Chromatin Interactions in Human Cells 3.09
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.04
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.01
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 2.94
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.87
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.87
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.85
Aging-associated patterns in the expression of human endogenous retroviruses 2.84
Transcriptome-wide response to synthetic chromatin protein PcTF 2.8
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.8
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.72
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.71
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.71
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.7
Macrophage Ad5f35 M2 Challenge 2.63
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.55
Transcriptome analysis of peripheral blood monocytes 2.54
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 2.49
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.48
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.47
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 2.45
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.43
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.41
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.41
6mer seed toxicity in viral microRNAs 2.34
Transcriptome analysis of CNS leukemia 2.29
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.29
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.26
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.24
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 2.23
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.18
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.18
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.18
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 2.15
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.15
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.03
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.98
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.98
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.96
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.93
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 1.9
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.84
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.83
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.8
Gene expression analysis of human hepatocellular cancers 1.75
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.74
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.73
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.6
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.58
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.58
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.57
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.56
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.56
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 1.56
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.52
mRNA-Seq profiling of human developing kidney 1.5
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.46
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.44
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.43
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.42
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.4
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 1.39
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.39
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.39
The role of the Calcium-Sensing receptor in colorectal cancer 1.28
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.22
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.22
Dilated cardiomyopathy vs Myocarditis 1.21
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.07
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.07
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.01
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 0.99
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.97
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.97
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.95
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.94
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.91
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.88
Transcriptomes in healthy and CHB fetal hearts 0.87
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.86
MCF-7 as a model for functional analysis of breast cancer risk variants 0.86
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.84
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.69
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.69
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.64
The contribution of Alu exons to the human proteome 0.62
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 0.61
HNRNPM-regulated splicing dependencies in prostate cancer 0.61
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.61
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.61
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.59
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.56
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.52
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.51
The role of m6A/m-RNA methylation in stress response regulation 0.51
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.48
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.48
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.47
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.46
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.41
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.41
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.41
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.36
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.24
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.24
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.22
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.22
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.2
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.2
Preclinical model of obesity and ER-positive breast cancer 0.19
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.12
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.12
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.11
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.11
Modulation of nonsense-mediated decay by rapamycin 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation